Skip to main content
. 2022 Jan 13;11:766576. doi: 10.3389/fonc.2021.766576

Table 3.

Comparative univariate and multivariate analyses of disease-free survival (DFS) and intravesical recurrence-free survival (IVRFS) in patients with UTUC.

DFS IVRFS
Univariate Multivariate Univariate Multivariate
HR (95% CI) p HR (95% CI) p HR (95% CI) p HR (95% CI) p
Gender
 Female 0.91 (0.76–1.10) 0.314 0.55 (0.46–0.66) <0.001** 0.60 (0.50–0.72) <0.001**
Age ≥70 1.36 (1.13–1.64) 0.001** 1.27 (1.05–1.54) 0.014* 1.04 (0.87–1.24) 0.689
CIS 1.06 (0.83–1.36) 0.645 1.22 (0.97–1.53) 0.092
Tumor size
Reference: <1 cm
 ≥1 and <2 cm 0.94 (0.58–1.53) 0.816 0.74 (0.45–1.21) 0.225 0.95 (0.67–1.34) 0.751
 ≥2 and <3 cm 1.40 (0.89–2.19) 0.145 0.99 (0.62–1.58) 0.956 0.88 (0.62–1.24) 0.452
 ≥3 cm 2.63 (1.75–3.97) <0.001** 1.35 (0.87–2.10) 0.184 0.99 (0.73–1.36) 0.972
Tumor location
 Renal pelvis 1.12 (0.92–1.37) 0.274 0.90 (0.75–1.09) 0.269
 Proximal ureter 1.23 (1.00–1.52) 0.053 1.17 (0.95–1.44) 0.133
 Middle ureter 1.26 (0.98–1.62) 0.071 1.28 (1.00–1.63) 0.046* 1.11 (0.86–1.43) 0.416
 Distal ureter 1.33 (1.07–1.65) 0.011* 1.23 (0.97–1.57) 0.084 1.70 (1.39–2.09) <0.001** 1.49 (1.20– 1.85) <0.001**
 Bladder cuff 2.41 (1.58–3.67) <0.001** 0.78 (0.49–1.25) 0.295 1.63 (1.02–2.61) 0.042* 1.07 (0.65– 1.76) 0.781
Multifocality 1.75 (1.45–2.11) <0.001** 1.27 (1.03–1.55) 0.024* 1.57 (1.31–1.88) <0.001** 1.30 (1.07–1.58) 0.010*
Preoperative hydronephrosis 1.37 (1.13–1.67) 0.002** 1.29 (1.04–1.59) 0.019* 1.29 (1.07–1.55) 0.008** 1.20 (0.99–1.46) 0.062
Lymphovascular invasion 3.26 (2.70–3.94) <0.001** 1.37 (1.10–1.69) 0.004** 1.07 (0.86–1.34) 0.545
Positive surgical margin 4.28 (3.14–5.83) <0.001** 1.84 (1.29–2.64) 0.001** 0.88 (0.50–1.57) 0.668
Tumor necrosis 1.85 (1.48–2.30) <0.001** 1.04 (0.82–1.32) 0.754 0.96 (0.75–1.24) 0.767
Tumor grading
 Low grade
 High grade 3.84 (2.56–5.74) <0.001** 1.93 (1.26–2.94) 0.002** 0.80 (0.64–0.997) 0.047* 0.81 (0.63–1.03) 0.084
Cell type
Reference: urothelial carcinoma (UC)
 UC with variants 2.14 (1.65–2.76) <0.001** 1.24 (0.94–1.64) 0.128 0.65 (0.44–0.95) 0.027* 0.69 (0.47–1.02) 0.065
Bladder UC
 Previous 1.08 (0.74–1.58) 0.684 1.30 (0.88–1.93) 0.183 2.02 (1.50–2.71) <0.001** 1.65 (1.22–2.23) 0.001**
 Synchronous 1.76 (1.41–2.20) <0.001** 1.62 (1.27–2.07) <0.001** 1.68 (1.34–2.10) <0.001** 1.33 (1.04–1.70) 0.022*
Pathological T stage
Reference: Ta/Tis
 T1 1.37 (0.87–2.16) 0.176 1.16 (0.72–1.86) 0.551 1.06 (0.82–1.39) 0.647 1.17 (0.89–1.53) 0.269
 T2 3.06 (2.01–4.67) <0.001** 1.99 (1.27–3.14) 0.003** 1.13 (0.86–1.50) 0.378 1.18 (0.87–1.59) 0.291
 T3 6.32 (4.29–9.30) <0.001** 3.52 (2.27–5.46) <0.001** 1.12 (0.87–1.45) 0.378 1.27 (0.96–1.69) 0.096
 T4 16.77 (10.63– 26.45) <0.001** 6.22 (3.65–10.60) <0.001** 0.28 (0.10–0.77) 0.013* 0.34 (0.12–0.93) 0.035*
Pathological N stage
Reference: N0
 N1 4.85 (3.03–7.76) <0.001** 3.57 (2.19–5.83) <0.001** 1.12 (0.55–2.30) 0.759
 N2 5.17 (3.50–7.65) <0.001** 2.71 (1.79–4.09) <0.001** 0.74 (0.36–1.52) 0.416
 Nx 1.04 (0.82–1.32) 0.759 1.23 (0.96–1.58) 0.110 0.97 (0.78–1.21) 0.802
RNU techniques
Reference: open
 Hand-assisted laparoscopic 0.76 (0.61–0.96) 0.020* 0.98 (0.77–1.25) 0.875 1.15 (0.90–1.48) 0.258
 Robot-assisted 0.80 (0.55–1.17) 0.249 1.01 (0.68–1.50) 0.953 1.11 (0.75–1.64) 0.611
 Laparoscopic 0.59 (0.45–0.78) <0.001** 0.73 (0.55–0.96) 0.027* 1.17 (0.89–1.54) 0.250
 LESS 0.34 (0.05–2.46) 0.286 0.20 (0.03–1.46) 0.111 0.83 (0.21–3.39) 0.800

* means “p < 0.05”; ** dictates “p < 0.01.